Current Pharmaceutical Design logo Bentham Science Publishers logo

Current Pharmaceutical Design publishes timely in-depth reviews covering all aspects of current research in rational drug design. Each issue is devoted to a single major therapeutic area. A Guest Editor who is an acknowledged authority in a therapeutic field has solicits for each issue comprehensive and timely reviews from leading researchers in the pharmaceutical industry and academia.

Each thematic issue of Current Pharmaceutical Design covers all subject areas of major importance to modern drug design, including: medicinal chemistry, pharmacology, drug targets and disease mechanism.

Publisher: Bentham Science Publishers

Volume 15, Number 27, September 2009
Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content

< previous issue | next issue > | all issues

Articles

Editorial [Hot Topic: Drugs Targeting Atherosclerosis: Current and Emerging Approaches (Executive Editors: Vangelis G. Manolopoulos and Anna Tavridou)]
pp. 3091-3093(3)
Authors: Manolopoulos, Vangelis G.; Tavridou, Anna

Anti-Atherosclerotic Molecules Targeting Oxidative Stress and Inflammation
pp. 3094-3107(14)
Authors: Adameova, A.; Xu, Y. J.; Duhamel, T. A.; Tappia, P. S.; Shan, L.; Dhalla, N. S.

Rho Kinase: An Important Mediator of Atherosclerosis and Vascular Disease
pp. 3108-3115(8)
Authors: Zhou, Qian; Liao, James K.

Inhibitors of the 5-Lipoxygenase Pathway in Atherosclerosis
pp. 3116-3132(17)
Author: Back, Magnus

Free Content Prevention of Atherosclerosis by Interference with the Vascular Nitric Oxide System
pp. 3133-3145(13)
Authors: Li, Huige; Forstermann, Ulrich

Recent Advances on the Antiatherogenic Effects of HDL-Derived Proteins and Mimetic Peptides
pp. 3146-3166(21)
Authors: Petraki, Maria P.; Mantani, Polyxeni T.; Tselepis, Alexandros D.

EP2300 Compounds: Focusing on the Antiatherosclerotic Properties of Squalene Synthase Inhibitors
pp. 3167-3178(12)
Authors: Tavridou, A.; Manolopoulos, V. G.

Oral Antidiabetic Agents: Anti-Atherosclerotic Properties Beyond Glucose Lowering?
pp. 3179-3192(14)
Authors: Papanas, N.; Maltezos, E.

Genomics and the Prospects of Existing and Emerging Therapeutics for Cardiovascular Diseases
pp. 3193-3206(14)
Authors: Zaiou, M.; Benachour, H.; Marteau, J. B.; Visvikis-Siest, S.; Siest, G.

< previous issue | next issue > | all issues

Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content
Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages.
Page Help Click here for Page Help
Shopping cart
Tools
Sign in






Need to register?
Sign up here
Text size: A | A | A | A